Variant report
Variant | esv3435990 |
---|---|
Chromosome Location | chr11:71978729-71981277 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:71980166..71983105-chr11:71990432..71992755,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000213365 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575507322 | chr11:71978775-71978776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs74978386 | chr11:71978786-71978787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11606083 | chr11:71978826-71978827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561120109 | chr11:71978835-71978836 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562043929 | chr11:71978949-71978950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561135916 | chr11:71978961-71978962 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573118156 | chr11:71978962-71978963 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540315607 | chr11:71979009-71979010 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565000622 | chr11:71979032-71979033 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79584582 | chr11:71979062-71979063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76387482 | chr11:71979063-71979064 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs77991976 | chr11:71979064-71979065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572510479 | chr11:71979076-71979077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532118564 | chr11:71979090-71979091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550566847 | chr11:71979106-71979107 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs139343077 | chr11:71979148-71979149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116216906 | chr11:71979155-71979156 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148993752 | chr11:71979247-71979248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567504362 | chr11:71979276-71979277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs118025109 | chr11:71979278-71979279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs143753439 | chr11:71979312-71979313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs148122996 | chr11:71979344-71979345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs59427981 | chr11:71979379-71979380 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs187156589 | chr11:71979486-71979487 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529146104 | chr11:71979522-71979523 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs55742041 | chr11:71979553-71979554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs55941613 | chr11:71979560-71979561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs55804185 | chr11:71979569-71979570 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547316483 | chr11:71979570-71979571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575598516 | chr11:71979572-71979573 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs377486828 | chr11:71979573-71979574 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536540708 | chr11:71979575-71979576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs55766410 | chr11:71979576-71979577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs56281216 | chr11:71979582-71979583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs56332049 | chr11:71979586-71979587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs56397287 | chr11:71979599-71979600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs56143657 | chr11:71979602-71979603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs141875220 | chr11:71979610-71979611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs146066511 | chr11:71979619-71979620 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs56160704 | chr11:71979635-71979636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540456039 | chr11:71979637-71979638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570892460 | chr11:71979641-71979642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs56308209 | chr11:71979645-71979646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs55769236 | chr11:71979652-71979653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs56055411 | chr11:71979665-71979666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs55739984 | chr11:71979670-71979671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs7121809 | chr11:71979671-71979672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34810387 | chr11:71979680-71979681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12796367 | chr11:71979681-71979682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs55776567 | chr11:71979685-71979686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Obesity | 19966786 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:71974400-71985600 | Weak transcription | Hela-S3 | cervix |
2 | chr11:71975400-71980200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
3 | chr11:71978000-71980400 | Weak transcription | A549 | lung |
4 | chr11:71978600-71980200 | Weak transcription | HepG2 | liver |
5 | chr11:71978800-71979600 | Enhancers | GM12878-XiMat | blood |
6 | chr11:71979600-71980000 | Weak transcription | GM12878-XiMat | blood |
7 | chr11:71980000-71981000 | Enhancers | GM12878-XiMat | blood |
8 | chr11:71980200-71980600 | Enhancers | HepG2 | liver |
9 | chr11:71980200-71981400 | Enhancers | Primary monocytes fromperipheralblood | blood |
10 | chr11:71980200-71981400 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
11 | chr11:71980400-71981000 | Enhancers | A549 | lung |
12 | chr11:71980400-71981200 | Enhancers | Placenta | Placenta |
13 | chr11:71980600-71984400 | Weak transcription | HepG2 | liver |
14 | chr11:71981000-71981200 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
15 | chr11:71981000-71981200 | Bivalent Enhancer | Primary T regulatory cells fromperipheralblood | blood |
16 | chr11:71981000-71981200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr11:71981000-71981400 | Flanking Active TSS | GM12878-XiMat | blood |
18 | chr11:71981000-71981400 | Active TSS | NHDF-Ad | bronchial |
19 | chr11:71981000-71983000 | Weak transcription | A549 | lung |